CClinicalTrials.gg
CompletedNCT01064700Updated Apr 28, 2021

Bright Light: A Novel Treatment for Anxiety

A Phase 1 interventional study of Litebook Bright Light Box and Litebook inactivated negation ion generator (the placebo) in Anxiety, Depression and Sleep, sponsored by University of South Carolina. Completed at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-28.

Sponsored by University of South Carolina · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The primary aim of this research was to examine the influence of bright light on anxiety in high-anxious young adults. In an acute exposure study, participants were randomly assigned to 45 min of either (1) bright light (3,000 lux) or (2) a placebo inactivated negative ion generator. Treatments were initiated ≤1 hr after awakening. At 10 min before and 30 min after the treatments, state anxiety, mood, and blood pressure were assessed.

Following the acute exposure study, participants performed a 5-week study. Following a a 1-week baseline, participants were randomly assigned to four weeks of daily exposure to either (1) bright light (45 min/day; 3,000 lux) or (2) placebo inactivated negative ion generator, which were initiated ≤1 hr after awakening. Before and after the experiment, clinical ratings were conducted with the Hamilton Anxiety Scale, the Hamilton Depression Scale, and the Clinical Global Impressions scale (CGI). Following baseline, and following each week of treatment, blood pressure, as well as questionnaires for state anxiety, depression, mood, sleep, and side effects were assessed.

02

Conditions studied

  • Anxiety
  • Depression
  • Sleep

Browse trials for

Keywords

  • Anxiety
  • Phototherapy
  • Psychic Anxiety
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 33 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

University of South Carolina is the lead sponsor of 191 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Having a level of trait anxiety [Spielberger State-Trait Anxiety Inventory (Form Y1)]{23642} that was ≥ the 75th percentile for their age (i.e., ≥ 46 and ≥ 44 for women and men, respectively)

Exclusion criteria

Exclusion Criteria:

  • Current treatment for anxiety or depression;
  • History of bipolar disorder, mania, or psychotic disorders;
  • History of winter depression, which might bias towards positive response to light;
  • Hypertension;
  • Ophthalmic abnormalities; and
  • Usual exposure to high levels of light such that the intervention would add little to usual exposure.
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
33 participants (actual)

Study arms

  • No intervention
    Baseline

    1 week period, in which subjects followed usual schedule, though they were asked to maintain a fairly stable sleep schedule. The baseline period was used for comparison with the experimental intervention.

  • Experimental
    Experimental Intervention

    Randomized exposure to the 4-week experimental treatments.

    Device: Litebook Bright Light Box · Device: Litebook inactivated negation ion generator (the placebo)

Interventions

  • DeviceLitebook Bright Light Box

    Four weeks of daily exposure to bright light (3,000 lux) for 45 min/day, beginning within 60 min of arising.

    Also known as: Phototherapy

  • DeviceLitebook inactivated negation ion generator (the placebo)

    Four weeks of daily exposure to inactivated negative ion generator for 45 min/day, beginning within 60 min of arising

    Also known as: Placebo

06

What researchers measure

Primary outcomes

  1. Spielberger State Anxiety Inventory

    state anxiety questionnaire

    Time frame: 5 weeks

  2. Hamilton Anxiety

    Hamilton Anxiety Questionnaire

    Time frame: 5 weeks

Secondary outcomes

  1. Beck Depression Inventory

    self-report depression questionnaire

    Time frame: 5 weeks

  2. Pittsburgh Sleep Quality Inventory

    PSQI, a common sleep quality questionnaire

    Time frame: 5 weeks

07

Study locations

1 site
  • Chronobiology Lab, University of South Carolina
    Columbia, South Carolina 29208, United States
08

References and documents

Publications

  • Youngstedt SD, Kline CE, Ginsberg JP, Zielinski MR, Hardin JW. Bright light treatment for high-anxious young adults: a randomized controlled pilot study. Depress Anxiety. 2011 Apr;28(4):324-32. doi: 10.1002/da.20784. Epub 2011 Jan 19. PubMed 21254315 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01064700
Lead sponsor
University of South Carolina
Collaborators
Liteboook Company
Responsible party
Shawn Youngstedt (Assistant Professor, University of South Carolina) — Principal investigator
First posted
Feb 8, 2010
Start date
Oct 2006
Primary completion
Dec 2007
Completion
Dec 2007
Last update
Apr 28, 2021

Study contacts

Shawn D Youngstedt
principal investigator · University of Southern California

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion